Dilated Cardiomyopathy Due to Methamphetamine Use in a Pregnant Patient: Case Report
Main Article Content
Abstract
Background: Dilated Cardiomyopathy (DCM) is characterized by dilation of the left ventricle (LV) and, by consequence contractile dysfunction. DCM is caused by multiple etiologies, often the result of myocarditis, alcohol consumption, drugs and metabolic or endocrine alterations.
Case: We report the case of a 36-year-old patient with a 27.6-week pregnancy with a pathological history of Heart Failure (HF) of 4 years, alcoholism of more than 15 years, methamphetamine use of more than 3 years. She presented agitation and class III dyspnea, the fatigue progressed until she presented respiratory distress accompanied by edema of the lower limbs, an echocardiogram was performed, Dilated Cardiomyopathy was diagnosed and therefore primary management was made with levosimendan and diuretic then cesarean surgery was performed.
Conclusion: for this patient the use of levosimendan was beneficial, improving the symptomatology, increasing the cardiac function and making possible the performance of the cesarean delivery. There was no harm for the patient or the baby.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Bouchez S, Fedele F, Giannakoulas G, Gustafsson F, Harjola V, Karason K et al. Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application. Cardiovascular Drugs and Therapy. 2018;32(6):617-624. doi: 10.1007/s10557-018-6838-2
II. Loscalzo J, Harrison T. Harrison 's Cardiovascular Medicine. 3rd ed. McGraw Hill; 2016.
III. Reddy P, Ng T, Oh E, Moady G, Elkayam U. Clinical Characteristics and Management of Methamphetamine‐Associated Cardiomyopathy: State‐of‐the‐Art Review. Journal of the American Heart Association. 2020;9(11). https://doi.org/10.1161/JAHA.120.016704
IV. Lilly L. Cardiología. Bases fisiopatológicas de las cardiopatías. 6th ed. Boston, Massachusetts: Wolters Kluwer; 2016.
V. Levine G. Cardiología. Secretos. 4th ed. Barcelona, España: Elsevier; 2014.
VI. Reichart D, Magnussen C, Zeller T, Blankenberg S. Dilated cardiomyopathy: from epidemiologic to genetic phenotypes. Journal of Internal Medicine. 2019;286(4):362-372. DOI: 10.1111/joim.12944
VII. Grewal J, Siu S, Ross H, Mason J, Balint O, Sermer M et al. Pregnancy Outcomes in Women With Dilated Cardiomyopathy. Journal of the American College of Cardiology. 2009;55(1):45-52. DOI: 10.1016/j.jacc.2009.08.036
VIII. Glinka L, Mayzner-Zawadzka E, Onichimowski D, Jalali R, Glinka M. Levosimendan in the modern treatment of patients with acute heart failure of various aetiologies. Archives of Medical Science. 2021;17(2):296-303.
doi: 10.5114/aoms.2018.77055
IX. Mahmaljy H, Yelamanchili V, Singhal M. Dilated Cardiomyopathy. Treasure Island (FL): StatPearls Publishing; 2021. PMID: 28722940
X. Villatoro-Velazquez J, Resendiz-Escobar E, Mujica-Salazar A, Breton-Cirett M, Cañas-Martinez V, Soto-Hernandez I et al. Encuesta Nacional de Consumo de Drogas, Alcohol y Tabaco 2016-2017: Reporte de Drogas. [Internet]. 1st ed. Ciudad de México, México: Instituto Nacional de Psiquiatria Ramon de la Fuente Muñiz; 2022 [cited 19 April 2022]. Available from:
https://encuestas.insp.mx/ena/encodat2017/reporte_encodat_drogas_2016_2017.pdf.